Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2024-04-05 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms the dematerialisation of securities for the quarter ended 31st March 2024, including acceptance/rejection of securities and updating the register of members. The document is a compliance confirmation letter from Link Intime India Pvt. Ltd. to Lyka Labs Limited. It does not contain financial data, management discussion, or report content but is a regulatory compliance confirmation. The document length is short (2335 characters) and is a certification/confirmation letter rather than a financial or management report. Therefore, it fits best under Regulatory Filings (RNS) as per the Certification Rule and fallback category for miscellaneous filings that do not fit other categories.
2024-04-05 English
Pursuant to Reg 74 (5) of the SEBI (DP) Regulations 2018, the Company enclosed herewith a certificate for the quarter ended 31st March 2024, as received from Registrar and Share Transfer ....
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms the dematerialisation of securities during the quarter ended 31st March 2024, including acceptance/rejection of securities and updating the register of members. The document is a compliance confirmation letter from a registrar and transfer agent to the company, not a financial report or announcement of financial results. It does not contain financial statements or management discussion, nor is it an announcement of voting results or capital changes. It is primarily a regulatory compliance confirmation, fitting best under Regulatory Filings (RNS). The document length is short and it is a certification-type letter, so per the Certification Rule, it should be classified as RNS.
2024-04-05 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document text is extremely short (465 characters) and consists solely of a digital signature block with no substantive content, financial data, or report information. There is no indication of a full report, announcement, or detailed filing. This matches the pattern of an officer certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2024-04-05 English
The Company has issue duplicate share certificates on 5th April 2024.
Regulatory Filings Classification · 95% confidence The document text is extremely short (465 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or detailed filing. Given the lack of content and the presence of a digital signature, this is likely an officer certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2024-04-05 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 113 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2024-04-03 English
Copy of Newspaper Publication
Legal Proceedings Report Classification · 95% confidence The document references a Notice of Hearing related to a Joint Petition concerning a Scheme of Amalgamation between two companies, filed before the National Company Law Tribunal. It mentions publication of notices in newspapers but does not contain financial data, audit information, or detailed report content. The document is short (1015 characters) and appears to be a regulatory announcement about legal proceedings related to a merger or amalgamation. This fits best under Legal Proceedings Report (LTR) as it updates on significant legal matters involving the company.
2024-04-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.